Evidence map›Paper›PMID 41717565›Full record

ReviewFrontiers in psychiatry2026

Transcranial magnetic stimulation in cocaine use disorder and the risk of seizure: a review of the evidence.

Caesar G Imperio, Eric Parmon, Vaughn R Steele, Derek Blevins, Rebecca Chalme, Jonathan M Wai, Kathleen Brady, Markus Heilig, Colleen A Hanlon, Frances R Levin and 1 more

Abstract readReview
In one paragraph

Review in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Caesar G ImperioNew York State Psychiatric Institute, Division on Substance Use Disorders, New York, NY, United States.
Eric ParmonNew York State Psychiatric Institute, Division on Substance Use Disorders, New York, NY, United States.
Vaughn R SteeleDepartment of Psychiatry, Yale School of Medicine, New Haven, CT, United States.
Derek BlevinsNew York State Psychiatric Institute, Division on Substance Use Disorders, New York, NY, United States.
Rebecca ChalmeNew York State Psychiatric Institute, Division on Substance Use Disorders, New York, NY, United States.
Jonathan M WaiNew York State Psychiatric Institute, Division on Substance Use Disorders, New York, NY, United States.
Kathleen BradyDepartment of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, United States.
Markus HeiligDepartment of Psychiatry, Center for Social and Affective Neuroscience, Linköping University, Linköping, Sweden.
Colleen A HanlonDepartment of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC, United States.
Frances R LevinNew York State Psychiatric Institute, Division on Substance Use Disorders, New York, NY, United States.
Diana MartinezNew York State Psychiatric Institute, Division on Substance Use Disorders, New York, NY, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transcranial magnetic stimulation (TMS) has emerged as a promising intervention for cocaine use disorder (CUD). However, a key concern when employing TMS in CUD is the potential risk of seizures. Our goal was to assess seizure risk in individuals with CUD undergoing TMS and to propose parameters that could mitigate it. Our review of the literature indicated that seizures are primarily associated with high-dose cocaine use necessitating urgent medical care - and that the risk is likely low outside of this setting. Thus, to mitigate potential seizure risks during TMS sessions, we suggest an assessment of recent cocaine use and an evaluation for cocaine toxicity. Additionally, rechecking motor threshold levels during treatment with TMS is recommended, especially if patterns of cocaine use change. Previous studies of TMS in CUD reported on two seizures that were linked to recent cocaine use rather than proximity to TMS treatment itself. Future research should document the timing of cocaine use relative to TMS sessions to further ensure the safety of this therapeutic approach.

Indexed as

addictioncocaineintoxicationseizuretoxicitytranscranial stimulation

Identifiers

PMID41717565
PMCPMC12913176

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.